mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 31 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | ACB143 | 2,668,473 | 0 | A | C | 57.9% | ‑0.1 / 11.4 | 19 | G234G (GGT→GGG) | CJ019_02525 | hypothetical protein |
| * | ACB143 | 5,693,175 | 0 | A | C | 55.1% | 3.4 / 26.1 | 53 | S236R (AGC→CGC) | pyrC' | Dihydroorotase‑like protein |
| * | ACB143 | 1,986,661 | 0 | A | C | 53.8% | 1.9 / 16.6 | 26 | intergenic (+42/+56) | mshA_1/CJ019_01891 | D‑inositol‑3‑phosphate glycosyltransferase/hypothetical protein |
| * | ACB143 | 3,608,495 | 0 | G | T | 53.6% | 3.2 / 17.7 | 28 | intergenic (+18/‑211) | tenA/codB | Aminopyrimidine aminohydrolase/Cytosine permease |
| * | ACB143 | 1,537,457 | 0 | T | G | 52.9% | 0.9 / 11.0 | 17 | V402G (GTG→GGG) | mdfA | Multidrug transporter MdfA |
| * | ACB143 | 994,246 | 0 | A | T | 52.4% | 6.8 / 15.3 | 26 | Q58L (CAG→CTG) | CJ019_00938 | hypothetical protein |
| * | ACB143 | 3,923,469 | 0 | A | C | 52.2% | 2.6 / 13.9 | 23 | W423G (TGG→GGG) | CJ019_03707 | hypothetical protein |
| * | ACB143 | 5,693,183 | 0 | T | G | 47.1% | 4.6 / 14.5 | 51 | R238R (CGT→CGG) | pyrC' | Dihydroorotase‑like protein |
| * | ACB143 | 5,530,421 | 0 | A | C | 46.4% | 50.4 / 20.6 | 56 | intergenic (‑53/+102) | livH_5/braC_2 | High‑affinity branched‑chain amino acidtransport system permease protein LivH/Leucine‑, isoleucine‑, valine‑, threonine‑, and alanine‑binding protein |
| * | ACB143 | 5,222,510 | 0 | G | C | 43.2% | 33.8 / 14.0 | 39 | intergenic (‑133/+43) | cntO_7/CJ019_04917 | Metal‑pseudopaline receptor CntO/hypothetical protein |
| * | ACB143 | 5,222,515 | 0 | T | A | 41.9% | 24.9 / 11.9 | 37 | intergenic (‑138/+38) | cntO_7/CJ019_04917 | Metal‑pseudopaline receptor CntO/hypothetical protein |
| * | ACB143 | 4,425,070 | 0 | G | C | 40.7% | 39.2 / 15.0 | 27 | intergenic (‑29/‑89) | CJ019_04200/CJ019_04201 | hypothetical protein/hypothetical protein |
| * | ACB143 | 188,021 | 0 | G | C | 38.8% | 36.5 / 15.9 | 49 | E960D (GAG→GAC) | CJ019_00185 | hypothetical protein |
| * | ACB143 | 6,043,196 | 0 | C | A | 36.9% | 40.4 / 31.0 | 65 | A37S (GCC→TCC) | puuD_3 | Gamma‑glutamyl‑gamma‑aminobutyrate hydrolasePuuD |
| * | ACB143 | 3,138,350 | 0 | T | G | 35.7% | 69.2 / 19.7 | 56 | F240V (TTT→GTT) | rbsC_2 | Ribose import permease protein RbsC |
| * | ACB143 | 2,113,895 | 0 | T | G | 35.1% | 47.6 / 10.8 | 39 | R663R (CGT→CGG) | CJ019_02007 | hypothetical protein |
| * | ACB143 | 188,012 | 0 | T | A | 34.7% | 40.6 / 25.1 | 49 | G957G (GGT→GGA) | CJ019_00185 | hypothetical protein |
| * | ACB143 | 1,123,271 | 0 | C | G | 34.2% | 41.7 / 10.6 | 38 | intergenic (‑273/+31) | gcvH_1/CJ019_01062 | Glycine cleavage system H protein/hypothetical protein |
| * | ACB143 | 452,940 | 0 | G | C | 32.3% | 107.8 / 16.5 | 65 | intergenic (‑36/+274) | pqqB/CJ019_00410 | Coenzyme PQQ synthesis protein B/hypothetical protein |
| * | ACB143 | 2,641,826 | 0 | A | C | 31.2% | 84.2 / 10.3 | 48 | Q36P (CAG→CCG) | CJ019_02499 | hypothetical protein |